Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women
Status:
COMPLETED
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to provide a theoretical basis for the rational use of cefditoren pivoxil in lactating women by conducting a pharmacokinetic study of cefditoren in the blood and milk of these women. The main questions it aims to answer are:
Can lactating women use cefditoren pivoxil? Is cefditoren distributed in breast milk?
12 Participants will:
Take cefditoren pivoxil tablets 200mg after a meal, and collect breast milk and plasma over certain time periods.